DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Citigroup Maintains Buy on Acceleron Pharma, Raises Price Target to $138

Citigroup maintains Acceleron Pharma (NASDAQ:XLRN) with a Buy and raises the price target from $75 to $138.

Benzinga · 01/29/2020 12:51

Citigroup maintains Acceleron Pharma (NASDAQ:XLRN) with a Buy and raises the price target from $75 to $138.